{"id":"https://openalex.org/A5036208168","orcid":"https://orcid.org/0000-0001-8730-5795","observed_orcids":["https://orcid.org/0000-0001-8730-5795"],"display_name":"Mark J. Mullin","raw_author_names":["Mark J. Mullin","Mark Mullin","Mullin, Mark"],"full_name":"Mark J. Mullin","works_count":9,"cited_by_count":34,"summary_stats":{"2yr_mean_citedness":3.5,"h_index":4,"i10_index":1},"ids":{"openalex":"https://openalex.org/A5036208168","orcid":"https://orcid.org/0000-0001-8730-5795","observed_orcids":["https://orcid.org/0000-0001-8730-5795"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210119210","ror":"https://ror.org/02jsvy381","display_name":"Chimerix (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119210"]},"years":[2025,2024,2022]}],"last_known_institutions":[{"id":"https://openalex.org/I4210119210","ror":"https://ror.org/02jsvy381","display_name":"Chimerix (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210119210"]}],"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":6,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","count":6,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","count":2,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","count":2,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11767","display_name":"Poxvirus research and outbreaks","count":2,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","value":3.17e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","value":2.34e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11767","display_name":"Poxvirus research and outbreaks","value":2e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","value":1.91e-05,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","value":1.39e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9179768562316895},{"id":"112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","score":0.8367282152175903},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.80846107006073},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.7806693315505981},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.5819000005722046}],"counts_by_year":[{"year":2022,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2024,"works_count":3,"oa_works_count":2,"cited_by_count":1},{"year":2025,"works_count":5,"oa_works_count":3,"cited_by_count":24},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":9}],"display_name_alternatives":["Mark J. Mullin","Mark Mullin","Mullin, Mark"],"block_key":"m mullin","works_api_url":"https://api.openalex.org/works?filter=author.id:A5036208168","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5036208168","updated_date":"2026-11-12T13:17:38","created_date":"2022-02-24T00:00:00"}